Raju Prasad
Chief Financial Officer · CRISPR Therapeutics AG
- 2024
- Aug 11, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Raju Prasad files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samarth Kulkarni - $10.47M in CRSP purchases and sales in the last 12 months
- James R. Kasinger - $1.32M in CRSP purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raju Prasad?
Raju Prasad is a corporate insider, tracked as Chief Financial Officer of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Raju Prasad submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Raju Prasad been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($5.10M) across all tracked filings.
